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Table S1.  Multiplicative effect of the T6’S mutation 
Mutation EC50 (mM) Hill n Imax (µA) Fold Shift 
WT 0.35 +/- 0.01 2.5 +/- 0.2 20 0.4-3.9 - 
T6'S 0.0080 +/- 0.0005 2.4 +/- 0.3 27 0.06-8 - 
Y206F 4.3 +/- 0.1 2.4 +/- 0.1 13 0.2-8 12.3 
T6'S/Y206F 0.10 +/- 0.01 2.6 +/- 0.3 14 0.14-7 12.5 
      
 
 
Table S2:  Effects of receptor mutagenesis on functional expression.  All mutations have 















WT 11 +/- 1 3.0 +/- 0.1 19 0.1-4 1.1 1.1 - - 
RRR_AAA 14 +/- 1 2.8 +/- 0.1 15 0.1-4 1.0 1.4 1 1 
RSR_AAA 14 +/- 1 2.6 +/- 0.1 15 0.1-3 0.6 0.6 -2 -2 
RRR/RSR_AAA 15 +/- 1 2.8 +/- 0.1 20 0.8-10 4.5 4.1 4 4 
LXXLE 14 +/- 1 3.2 +/- 0.1 12 0.02-0.23 0.1 0.15 -11 -8 
M3-M4 loop No response 
α signal peptide  
(no T6'S) 980 +/- 20 1.9 +/- 0.1 16 3-14 8.9 8.7 9 8 
α signal peptide 
+ α1 (no T6'S) 110 +/- 10 2.6 +/- 0.2 14 0.2-6 1.0 1.4 1 1 
M4-C term β/α No response 
 
 
Table S3. Unnatural amino acid mutagenesis of Y206 with the α signal sequence for 
enhanced expression.  All mutants have the T6’S background mutation. 
 
EC50 (mM) Hill n Imax (µA) Fold Shift 
WT 0.93 +/- 0.02 1.8 +/- 0.1 26 2-13 - 
T6'S 0.013 +/- 0.001 2.7 +/- 0.2 17 2-13 - 
T6'S/Y206F 0.25 +/- 0.01 2.7 +/- 0.1 17 0.6-17 - 
Phe 0.25 +/- 0.01 2.5 +/- 0.1 20 0.06-12 - 
F1-Phe 1.4 +/- 0.1 2.8 +/- 0.5 15 0.4-6 6 
F2-Phe >100 20 0.1-1   
OMe-Phe 0.64 +/- 0.01 2.9 +/- 0.1 11 0.3-6 3 
Br-Phe 1.5 +/- 0.1 3.1 +/- 0.1 11 1-13 6 





Figure S1.  The M2 pore lining helix of GluClβ.  Helices from two adjacent subunits are 
shown.View from (A) the top of the receptor and (B) from “inside the pore” (roughly 
from where the word “Pore” is in part A).  Residues in the ion-conducting pore are 
highlighted in blue and the location of the 0’ arginine, 6’ threonine, 9’ leucine, and 20’ 
alanine are indicated.  Side chains of the GluClα crystal structure were mutated to the 


















ACH4_HUMAN : KITLCISVLLSLTVFLLLITEI  
ACH2_HUMAN : KITLCISVLLSLTVFLLLITEI  
ACHD_HUMAN : KTSVAISVLLAQSVFLLLISKR  
ACHB_HUMAN : KMGLSIFALLTLTVFLLLLADK  
5HT3_HUMAN : RVSFKITLLLGYSVFLIIVSDT  
GAA4_HUMAN : RTVFGITTVLTMTTLSISARHS 
GAB1_HUMAN : RVALGITTVLTMTTISTHLRET  
GRA1_HUMAN : RVGLGITTVLTMTTQSSGSRAS 
GluCl-alph : RVTLGVTTLLTMTAQSAGINSQ 




Figure S2.  Sequence alignment of GluClα and GluClβ.  Sites for chimera synthesis and 
receptor mutagenesis are indicated:  α signaling peptide chimera spliced at red line, α 
signaling peptide + α1 helix spliced at orange line, M3-M4 loop spliced between green 
lines, C terminus spliced at purple line, and putative ER retention RxR motifs and ER 
export LxxLE motif are highlighted in black boxes.  Residues targeted for mutagenesis 
are highlighted in red.  Sequence alignment was made using Clustal Omega.  Also shown 
are alignments of the M2 regions of several Cys-loop receptor subunits:  nicotinic 





Figure S3.  Effects of mutations and chimeras on GluClβ functional expression.  (A) 
Schematic of chimeras examined and (B) average and median currents from X. laevis 
oocytes expressing the specified mutant receptor. 
 
EC domain M1 M2 M3 M4 
Signal 
peptide Glu (µA) IVM (µA) 
3-14 NR GluCl   Sig. 
GluCl  NR 3-8 
GluCl  0.4-4 NR 
GluCl / /  
M3-M4 loop 
NR NR 
GluCl /  C term NR NR 







Figure  S4.  EC50 plots of mutant receptors that demonstrate a large loss-of-function. (A) 
Y206CNPhe with the α signal sequence (B) Y206CNPhe with the WT β signal sequence 
(C) Y156F2Phe (D) Y206F2Phe with the α signal sequence (E) Y206F2Phe with the WT 
β signal sequence (F)Y156F3Phe with the α signal sequence (G) Y156F3Phe the WT β 
signal sequence 
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